p.133 抽出テキスト

phaseIVʻreal lifeʼtrial on the variability of response to opioids. Ann Oncol 2016;27:1107‒15 3) Haumann J, van Kuijk SMJ, Geurts JW, et al. Methadone versus fentanyl in patients with radiation‒induced nociceptive pain with head and neck cancer:a randomized controlled noninferiority trial. Pain Pract 2018;18:331‒40 4) Haumann J, Geurts JW, van Kuijk SM, et al. Methadone is superior to fentanyl in treating neuropathic pain in patients with head‒and‒neck cancer. Eur J Cancer 2016;65:121‒9 5) Raptis E, Vadalouca A, Stavropoulou E, et al. Pregabalin vs. opioids for the treatment of neuropathic cancer pain:a prospective, head‒to‒head, randomized, open‒label study. Pain Pract 2014;14:32‒42 6) Wirz S, Wittmann M, Schenk M, Gastrointestinal symptoms under opioid therapy:a prospective comparison of oral sustained‒release hydromorphone, transdermal fentanyl, and transdermal buprenorphine. Eur J Pain 2009;13:737‒43 7) Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained‒release oral morphine in cancer pain:preference, efficacy, and quality of life. The TTS‒Fentanyl Comparative Trial Group. J Pain Symptom Manage 1997;13:254‒61 8) Kongsgaard UE, Poulain P. Transdermal fentanyl for pain control in adults with chronic cancer pain. Eur J Pain 1998;2:53‒62 9) Kress HG, Von der Laage D, Hoerauf KH, et al. A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain. J Pain Symptom Manage 2008;36: 268‒79 10) Mercadante S, Porzio G, Ferrera P, et al. Sustained‒release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain 2008;12:1040‒6 11) Mystakidou K, Katsouda E, Kouloulias V, et al. Comparison of transdermal fentanyl with codeine/paracetamol, in combination with radiotherapy, for the management of metastatic bone pain. J Opioid Manag 2005;1:204‒10 12) Pistevou‒Gompaki K, Kouloulias VE, Varveris C, et al. Radiotherapy plus either transdermal fentanyl or paracetamol and codeine for painful bone metastases:a randomised study of pain relief and quality of life. Curr Med Res Opin 2004;20:159‒63 13) van Seventer R, Smit JM, Schipper RM, et al. Comparison of TTS‒fentanyl with sustained‒ release oral morphine in the treatment of patients not using opioids for mild‒to‒moderate pain. Curr Med Res Opin 2003;19:457‒69 14) Wong JO, Chiu GL, Tsao CJ, et al. Comparison of oral controlled‒release morphine with trans-

dermal fentanyl in terminal cancer pain. Acta Anaesthesiol Sin 1997;35:25‒32

【参考文献】a) Hadley G, Derry S, Moore RA, et al. Transdermal fentanyl for cancer pain. Cochrane Database Syst Rev 2013;10:CD010270 b) Kang JH, Oh SY, Song SY, et al. The efficacy of low‒dose transdermal fentanyl in opioid‒naïve cancer patients with moderate‒to‒severe pain. Korean J Intern Med 2015;30:88‒95 c) Mercadante S, Porzio G, Ferrera P, et al. Low doses of transdermal fentanyl in opioid‒naive

patients with cancer pain. Curr Med Res Opin 2010;26:2765‒8